Just weeks after in-licensing a series of cholesterol-related compounds, QuatRx Pharmaceuticals Co. raised $28 million in venture capital financing. (BioWorld Today)
Just weeks after in-licensing a series of cholesterol-related compounds, QuatRx Pharmaceuticals Co. raised $28 million in venture capital financing. (BioWorld Today)
MedImmune Inc. expanded its oncology pipeline after licensing North American rights to a clinical candidate from a German company, while at the same time taking an equity stake in the privately held firm. (BioWorld Today)
MedImmune Inc. expanded its oncology pipeline after licensing North American rights to a clinical candidate from a German company, while at the same time taking an equity stake in the privately held firm. (BioWorld Today)
Serono SA and Biogen Inc. continued to lob fire at each other in their battle to prove superiority in the multiple sclerosis drug space.(BioWorld Today)
